Overview

  • Product nameAnti-Als2 antibody
    See all Als2 primary antibodies
  • Description
    Mouse monoclonal to Als2
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Recombinant fragment: PSQDLKPVPE RCNQCSQLLI TMTDKEDHVI ISDSHCCPLG VTLTESQAEN HASTALSPST ETLDRQEEVF ENTLVANDQS VATELNAVSA QITSSDAMSS , corresponding to amino acids 221-321 of Human Als2

Properties

Applications

Our Abpromise guarantee covers the use of ab57550 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB
  • Application notesWB: Use at a concentration of 1-5 µg/ml.

    This antibody has only been tested in WB against the recombinant fragment used as immunogen. We have no data on the detection of endogenous protein.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionMay act as a GTPase regulator. Controls survival and growth of spinal motoneurons.
    • Involvement in diseaseDefects in ALS2 are the cause of amyotrophic lateral sclerosis type 2 (ALS2) [MIM:205100]. ALS2 is a familial form of amyotrophic lateral sclerosis, a neurodegenerative disorder affecting upper and lower motor neurons and resulting in fatal paralysis. Sensory abnormalities are absent. Death usually occurs within 2 to 5 years. The etiology of amyotrophic lateral sclerosis is likely to be multifactorial, involving both genetic and environmental factors. The disease is inherited in 5-10% of cases leading to familial forms.
      Defects in ALS2 are the cause of juvenile primary lateral sclerosis (JPLS) [MIM:606353]. JPLS is a neurodegenerative disorder which is closely related to but clinically distinct from amyotrophic lateral sclerosis. It is a progressive paralytic disorder which results from dysfunction of the upper motor neurons of the motor cortex while the lower neurons are unaffected.
      Defects in ALS2 are the cause of infantile-onset ascending spastic paralysis (IAHSP) [MIM:607225]. IAHSP is characterized by progressive spasticity and weakness of limbs.
    • Sequence similaritiesContains 1 DH (DBL-homology) domain.
      Contains 8 MORN repeats.
      Contains 1 PH domain.
      Contains 5 RCC1 repeats.
      Contains 1 VPS9 domain.
    • Post-translational
      modifications
      Phosphorylated upon DNA damage, probably by ATM or ATR.
    • Information by UniProt
    • Database links
    • Alternative names
      • ALS 2 antibody
      • ALS2 antibody
      • ALS2_HUMAN antibody
      • ALS2CR6 antibody
      • Alsin antibody
      • ALSJ antibody
      • Amyotrophic lateral sclerosis 2 (juvenile) antibody
      • Amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 6 antibody
      • Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein antibody
      • Amyotrophic lateral sclerosis 2 protein antibody
      • Amyotrophic lateral sclerosis protein 2 antibody
      • FLJ31851 antibody
      • IAHSP antibody
      • KIAA1563 antibody
      • MGC87187 antibody
      • PLSJ antibody
      see all

    Anti-Als2 antibody images

    • Western blot against tagged recombinant protein immunogen using ab57550 Als2 antibody at 1ug/ml. Predicted band size of immunogen is 37 kDa

    References for Anti-Als2 antibody (ab57550)

    ab57550 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab57550.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"